
Glaukos Corporation GKOS
€ 135.98
0.91%
Land |
|
IPO-Jahr |
2015 |
Branche |
Medizinische Instrumente |
Börse |
NYSESPB |
Anteile |
57.2 M |
Marktkapitalisierung |
$ 8.86 B |
EBITDA (LTM) |
$ -162 M |
P/E (LTM) |
-54.106707 |
P/S (LTM) |
20.001319 |
EPS (LTM) |
-3.28 |
Andere Aktien der Branche "Medizinische Instrumente"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Becton, Dickinson and Company
BDX
|
$ 179.23 | 0.24 % | $ 51.6 B | NYSE,SPB | ||
|
BioLife Solutions
BLFS
|
$ 38.58 | 2.23 % | $ 1.84 B | Nasdaq Global Select Market | ||
|
electroCore
ECOR
|
$ 11.35 | 1.01 % | $ 96.3 K | Nasdaq Global Select Market | ||
|
Harvard Bioscience
HBIO
|
$ 8.02 | 0.25 % | $ 356 M | Nasdaq Global Market | ||
|
InfuSystem Holdings
INFU
|
$ 12.69 | 0.24 % | $ 262 M | NYSE American | ||
|
iRhythm Technologies
IRTC
|
$ 110.8 | 0.15 % | $ 3.55 B | Nasdaq Global Select Market,SPB | ||
|
Intuitive Surgical
ISRG
|
$ 399.52 | 0.31 % | $ 143 B | Nasdaq Global Select Market,SPB | ||
|
Alcon
ALC
|
$ 64.56 | 0.02 % | $ 31.8 B | NYSE | ||
|
Repro Med Systems
KRMD
|
$ 3.27 | 0.31 % | $ 151 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 80.82 | 0.3 % | $ 1.83 B | Nasdaq Global Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 1.31 | 0.38 % | $ 60 M | Nasdaq Global Select Market | ||
|
Merit Medical Systems
MMSI
|
$ 87.3 | 0.26 % | $ 5.16 B | Nasdaq Global Select Market,SPB | ||
|
Nephros
NEPH
|
$ 4.14 | 2.88 % | $ 43.9 M | Nasdaq Global Select Market | ||
|
Envista Holdings Corporation
NVST
|
$ 24.07 | 1.03 % | $ 4.04 B | NYSE | ||
|
OraSure Technologies
OSUR
|
$ 3.93 | 0.63 % | $ 289 M | Nasdaq Global Select Market,SPB | ||
|
AngioDynamics
ANGO
|
$ 15.28 | 0.26 % | $ 635 M | Nasdaq Global Select Market | ||
|
Pro-Dex
PDEX
|
$ 73.02 | 1.5 % | $ 236 B | Nasdaq Global Select Market | ||
|
Pulse Biosciences
PLSE
|
$ 51.83 | 0.93 % | $ 3.49 B | Nasdaq Global Select Market | ||
|
Repligen Corporation
RGEN
|
$ 190.65 | 3.32 % | $ 10.7 M | Nasdaq Global Select Market,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.68 | 0.74 % | $ 20.4 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 19.08 | 0.38 % | $ 946 M | Nasdaq Global Market,SPB | ||
|
STERIS plc
STE
|
$ 208.77 | 0.1 % | $ 20.5 B | NYSE,SPB | ||
|
Stereotaxis
STXS
|
$ 1.29 | 2.94 % | $ 117 M | NYSE American | ||
|
Teleflex Incorporated
TFX
|
$ 120.09 | 0.31 % | $ 5.36 B | NYSE,SPB | ||
|
Baxter International
BAX
|
$ 23.48 | 0.09 % | $ 12 B | NYSE,SPB | ||
|
AtriCure
ATRC
|
$ 60.77 | 1.36 % | $ 2.9 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 106.0 | 0.2 % | $ 5 B | NYSE,SPB | ||
|
The Cooper Companies
COO
|
$ 55.38 | 1.41 % | $ 11 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 166.02 | 1.65 % | $ 4.09 B | Nasdaq Global Select Market,SPB | ||
|
Milestone Scientific
MLSS
|
$ 0.41 | 1.2 % | $ 33.6 M | NYSE American | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Utah Medical Products
UTMD
|
$ 74.75 | 0.05 % | $ 242 M | Nasdaq Global Select Market | ||
|
ResMed
RMD
|
$ 221.89 | 0.19 % | $ 32.3 B | NYSE,SPB | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
West Pharmaceutical Services
WST
|
$ 373.6 | 1.26 % | $ 27 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 9.53 | 0.05 % | $ 1.9 B | Nasdaq Global Select Market,SPB | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
Ekso Bionics Holdings
EKSO
|
- | - | $ 28.6 M | Nasdaq Capital Market | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Masimo Corporation
MASI
|
- | - | $ 9.59 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market |